Beth Eaby

864 total citations
10 papers, 665 citations indexed

About

Beth Eaby is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Beth Eaby has authored 10 papers receiving a total of 665 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Surgery. Recurrent topics in Beth Eaby's work include Colorectal Cancer Treatments and Studies (6 papers), Lung Cancer Treatments and Mutations (5 papers) and HER2/EGFR in Cancer Research (4 papers). Beth Eaby is often cited by papers focused on Colorectal Cancer Treatments and Studies (6 papers), Lung Cancer Treatments and Mutations (5 papers) and HER2/EGFR in Cancer Research (4 papers). Beth Eaby collaborates with scholars based in United States, United Kingdom and South Africa. Beth Eaby's co-authors include Mario E. Lacouture, Dennis P. West, Thomas J. Lynch, Jody S. Garey, Luke Velders, Alex Molassiotis, Peter Coventry, Carrie Tompkins Stricker, Ann Culkin and Caroline Clements and has published in prestigious journals such as The Oncologist, Journal of Pain and Symptom Management and Journal of Thoracic Oncology.

In The Last Decade

Beth Eaby

10 papers receiving 630 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Beth Eaby United States	8	424	189	180	139	79	10	665
Corina J. van den Hurk Netherlands	8	377 0.9×	77 0.4×	55 0.3×	299 2.2×	19 0.2×	8	583
David D. Biggs United States	10	231 0.5×	238 1.3×	71 0.4×	33 0.2×	15 0.2×	20	570
Diane Severin Canada	16	284 0.7×	256 1.4×	225 1.3×	21 0.2×	8 0.1×	51	696
Thomas Kegel Germany	11	184 0.4×	78 0.4×	63 0.3×	53 0.4×	47 0.6×	38	398
C. Collis United Kingdom	14	87 0.2×	165 0.9×	127 0.7×	21 0.2×	20 0.3×	26	484
Kunal C. Kadakia United States	13	208 0.5×	93 0.5×	90 0.5×	67 0.5×	6 0.1×	43	455
Jakub Kucharz Poland	12	226 0.5×	101 0.5×	173 1.0×	27 0.2×	7 0.1×	47	575
Juan Antonio Virizuela Spain	12	231 0.5×	127 0.7×	165 0.9×	12 0.1×	16 0.2×	57	587
S. Malamud United States	12	242 0.6×	177 0.9×	128 0.7×	13 0.1×	7 0.1×	40	539
Toshihiko Aranishi Japan	9	289 0.7×	38 0.2×	38 0.2×	174 1.3×	17 0.2×	20	388

Countries citing papers authored by Beth Eaby

Since Specialization

Citations

This map shows the geographic impact of Beth Eaby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beth Eaby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beth Eaby more than expected).

Fields of papers citing papers by Beth Eaby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beth Eaby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beth Eaby. The network helps show where Beth Eaby may publish in the future.

Co-authorship network of co-authors of Beth Eaby

This figure shows the co-authorship network connecting the top 25 collaborators of Beth Eaby. A scholar is included among the top collaborators of Beth Eaby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beth Eaby. Beth Eaby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Malhotra, Binu, Tracey L. Evans, Jared Weiss, et al.. (2010). Carboplatin/Pemetrexed/Bevacizumab in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Single-Institution Experience. Clinical Lung Cancer. 11(3). 192–197. 10 indexed citations

2.

Weiss, Jared, Beth Eaby, James Stevenson, et al.. (2010). Adjuvant Cisplatin and Docetaxel for Non-small Cell Lung Cancer: The Hospital of the University of Pennsylvania Experience. Journal of Thoracic Oncology. 5(5). 667–672. 3 indexed citations

3.

Lacouture, Mario E., Michael L. Maitland, Siegfried Segaert, et al.. (2010). A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC skin toxicity study group. Supportive Care in Cancer. 18(4). 509–522. 107 indexed citations

4.

Thatcher, Nicholas, M. Nicolson, Richard Groves, et al.. (2009). Expert Consensus on the Management of Erlotinib-Associated Cutaneous Toxicity in the U.K.. The Oncologist. 14(8). 840–847. 30 indexed citations

5.

Eaby, Beth, Ann Culkin, & Mario E. Lacouture. (2008). An Interdisciplinary Consensus on Managing Skin Reactions Associated With Human Epidermal Growth Factor Receptor Inhibitors. Clinical journal of oncology nursing. 12(2). 283–290. 50 indexed citations

6.

Molassiotis, Alex, Carrie Tompkins Stricker, Beth Eaby, Luke Velders, & Peter Coventry. (2008). Understanding the concept of chemotherapy-related nausea: the patient experience. European Journal of Cancer Care. 17(5). 444–453. 55 indexed citations

7.

Molassiotis, Alex, Peter Coventry, Carrie Tompkins Stricker, et al.. (2007). Validation and Psychometric Assessment of a Short Clinical Scale to Measure Chemotherapy-Induced Nausea and Vomiting: The MASCC Antiemesis Tool. Journal of Pain and Symptom Management. 34(2). 148–159. 129 indexed citations

8.

Lynch, Thomas J., et al.. (2007). Epidermal Growth Factor Receptor Inhibitor–Associated Cutaneous Toxicities: An Evolving Paradigm in Clinical Management. The Oncologist. 12(5). 610–621. 263 indexed citations

9.

Veronese, Maria Luisa, Beth Eaby, Jane Β. Alavi, et al.. (2005). Gefitinib in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC): The Expanded Access Protocol Experience at the University of Pennsylvania. Cancer Investigation. 23(4). 296–302. 16 indexed citations

10.

Veronese, Maria Luisa, Beth Eaby, Jane Β. Alavi, et al.. (2005). Gefitinib in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC): The Expanded Access Protocol Experience at the University of Pennsylvania. Cancer Investigation. 23(4). 296–302. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact